Description: Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
595 Madison Avenue
New York,
NY
10017
United States
Phone:
917 289 2776
Officers
Name | Title |
---|---|
Mr. Humphrey P. Polanen | CEO & Chairman |
Ms. Weixuan Luo CPA, MS | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2021-12-02 |
Fiscal Year End: | March |
Full Time Employees: | 0 |